4D Molecular Therapeutics, Inc. (FDMT)

4D Molecular Therapeutics Statistics

Total Valuation

FDMT has a market cap or net worth of $368.43 million. The enterprise value is -$137.06 million.

Market Cap	368.43M
Enterprise Value	-137.06M

Important Dates

The last earnings date was Wednesday, November 13, 2024, after market close.

Earnings Date	Nov 13, 2024
Ex-Dividend Date	n/a

Share Statistics

FDMT has 46.23 million shares outstanding. The number of shares has increased by 38.91% in one year.

Current Share Class	46.23M
Shares Outstanding	46.23M
Shares Change (YoY)	+38.91%
Shares Change (QoQ)	+0.49%
Owned by Insiders (%)	3.93%
Owned by Institutions (%)	84.56%
Float	30.82M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	72.97
PB Ratio	0.79
P/TBV Ratio	0.66
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 17.33, with a Debt / Equity ratio of 0.04.

Current Ratio	17.33
Quick Ratio	17.03
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -32.50% and return on invested capital (ROIC) is -22.81%.

Return on Equity (ROE)	-32.50%
Return on Assets (ROA)	-21.80%
Return on Capital (ROIC)	-22.81%
Revenue Per Employee	$116
Profits Per Employee	-$976,054
Employee Count	147
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -33.66% in the last 52 weeks. The beta is 2.80, so FDMT's price volatility has been higher than the market average.

Beta (5Y)	2.80
52-Week Price Change	-33.66%
50-Day Moving Average	9.73
200-Day Moving Average	20.03
Relative Strength Index (RSI)	43.26
Average Volume (20 Days)	769,281

Short Selling Information

The latest short interest is 8.18 million, so 17.70% of the outstanding shares have been sold short.

Short Interest	8.18M
Short Previous Month	9.49M
Short % of Shares Out	17.70%
Short % of Float	26.55%
Short Ratio (days to cover)	9.89

Income Statement

In the last 12 months, FDMT had revenue of $17,000 and -$143.48 million in losses. Loss per share was -$2.83.

Revenue	17,000
Gross Profit	-124.22M
Operating Income	-168.38M
Pretax Income	-109.89M
Net Income	-143.48M
EBITDA	-163.72M
EBIT	-168.38M
Loss Per Share	-$2.83

Balance Sheet

The company has $501.89 million in cash and $24.83 million in debt, giving a net cash position of $525.84 million or $11.37 per share.

Cash & Cash Equivalents	501.89M
Total Debt	24.83M
Net Cash	525.84M
Net Cash Per Share	$11.37
Equity (Book Value)	552.95M
Book Value Per Share	10.63
Working Capital	481.29M

Cash Flow

In the last 12 months, operating cash flow was -$113.37 million and capital expenditures -$3.39 million, giving a free cash flow of -$116.76 million.

Operating Cash Flow	-113.37M
Capital Expenditures	-3.39M
Free Cash Flow	-116.76M
FCF Per Share	-$2.53

Margins

Gross Margin	n/a
Operating Margin	-990,447.06%
Pretax Margin	-844,000.00%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-431.13%

Dividends & Yields

FDMT does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-38.91%
Shareholder Yield	-38.91%
Earnings Yield	-39.09%
FCF Yield	-31.81%

Analyst Forecast

The average price target for FDMT is $46.75, which is 486.58% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$46.75
Price Target Difference	486.58%
Analyst Consensus	Strong Buy
Analyst Count	9
Revenue Growth Forecast (5Y)	69.99%
EPS Growth Forecast (5Y)	-0.86%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FDMT has an Altman Z-Score of 10.29 and a Piotroski F-Score of 1.

Altman Z-Score	10.29
Piotroski F-Score	1